OTC Link · Healthcare · Biotechnology
REVIVA PHARMA HLDGS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Q1 2026 | -0.38 | -0.46 | -21.05% | $0 | ❌ Miss | -0.88% | +11.08% | — |
| 2026-03-30 | Q4 2025 | -1.04 | -0.57 | +45.48% | $0 | ✅ Beat | -2.63% | +7.88% | +31.33% |
| 2025-11-13 |
| Q3 2025 |
| -0.10 |
| -0.06 |
| +40.00% |
| $0 |
| ✅ Beat |
| — |
| — |
| — |
| 2025-03-31 | Q4 2024 | -0.21 | -0.15 | +28.57% | $0 | ✅ Beat | -34.91% | -37.09% | -6.69% |
| 2024-11-14 | Q3 2024 | -0.25 | -0.25 | +0.00% | $0 | ➖ Inline | -7.02% | +2.48% | +90.08% |
| 2024-08-14 | Q2 2024 | -0.29 | -0.26 | +10.34% | $0 | ✅ Beat | -4.60% | +18.03% | +67.11% |
| 2024-05-14 | Q1 2024 | -0.42 | -0.25 | +40.48% | $0 | ✅ Beat | -6.30% | -28.49% | -17.81% |
| 2024-04-15 | Q4 2023 | -0.32 | -0.35 | -9.38% | $0 | ❌ Miss | -4.31% | -11.21% | -50.86% |
Showing last 8 quarters.